Comparison of two multiplexed technologies for profiling >1,000 serum proteins that may associate with tumor burden
F1000Research, 2021
Ren A., Prassas I., Sugumar V., Soosaipillai A., Bernardini M., Diamandis E., Kulasingam V.
| Disease area | Application area | Sample type | Products |
|---|---|---|---|
Oncology | Technical Evaluation | Serum |  Olink Target 96 |
Abstract
No abstract available for this publication.